MRNA Latest Press Releases

-- December 9, 2025 --

Global AI Infrastructure Shift Ignites Biotech Growth Phase Globe Newswire 9:25 AM

-- November 20, 2025 --

Moderna Analyst Day Highlights Pipeline Progress and Business Strategy Updates ACCESS Newswire 7:00 AM

Moderna Secures $1.5 Billion Five-Year Credit Facility from Ares Management ACCESS Newswire 7:00 AM

-- November 19, 2025 --

Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities ACCESS Newswire 7:00 AM

-- November 18, 2025 --

Moderna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025 ACCESS Newswire 7:00 AM

-- November 6, 2025 --

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates ACCESS Newswire 7:00 AM

-- November 3, 2025 --

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma ACCESS Newswire 7:00 AM

-- October 23, 2025 --

Moderna Named a Top Employer by Science for Eleventh Consecutive Year ACCESS Newswire 2:43 PM

Moderna to Host Investor Event - Analyst Day ACCESS Newswire 7:00 AM

-- October 22, 2025 --

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint ACCESS Newswire 4:05 PM

-- October 19, 2025 --

Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 ACCESS Newswire 8:00 AM

-- October 16, 2025 --

Moderna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 ACCESS Newswire 7:00 AM

-- October 12, 2025 --

Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress ACCESS Newswire 6:05 PM

-- September 24, 2025 --

Moderna Opens State-of-the-Art Manufacturing and R&D Facility in the UK ACCESS Newswire 7:11 PM

-- September 23, 2025 --

Moderna Announces mNEXSPIKE Generates Strong Immune Response Against LP.8.1 Variant in Humans ACCESS Newswire 7:11 AM

-- September 19, 2025 --

Moderna Announces First Made-in-Canada mRNA Vaccines Delivered to Canadian Provinces and Territories ACCESS Newswire 3:21 PM

-- September 16, 2025 --

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans ACCESS Newswire 6:11 AM

-- September 2, 2025 --

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism ACCESS Newswire 7:05 AM

-- September 1, 2025 --

VOO ETF News, 9/1/2025 TipRanks 7:39 AM

SPY ETF News, 9/1/2025 TipRanks 7:39 AM

??? ??? ???? ???? ? ?? '??' ??? ???? ? CDC ?? ???? ???: '?? ??? ???'? ?? ? Shomik Sen Bhattacharjee 3:47 AM

Le leadership de Robert Kennedy Jr. ne peut apporter que plus de "dommages", dclare un haut responsable de l'ancien CDC : "Le dmantlement de la vaccination" est en cours Shomik Sen Bhattacharjee 3:47 AM

????????Jr.???????????CDC????????????????????????????????????????????? Shomik Sen Bhattacharjee 3:47 AM

??? ???? ?????? ????? ?????? ??????? ??????: "????? ????? ?????? ?????? ?????? ??? ????? ?????? ?? ?????: '????? ???????' ?? ???????". Shomik Sen Bhattacharjee 3:47 AM

??????????????????"??",?????????????:"???????????" Shomik Sen Bhattacharjee 3:47 AM

Il leadership di Robert Kennedy Jr. pu solo portare pi "danno", afferma il ex funzionario di alto livello dei CDC: "Disfazione della vaccinazione" in corso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Fhrung wird laut einem fhrenden ehemaligen CDC-Beamten nur noch mehr "Schaden" bringen: "Rckgngigmachung der Impfung" in Arbeit Shomik Sen Bhattacharjee 3:47 AM

El liderazgo de Robert Kennedy Jr. solo puede traer ms "dao", dice alto exfuncionario de los CDC: "Desmantelamiento de la vacunacin" en proceso Shomik Sen Bhattacharjee 3:47 AM

Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In Works Shomik Sen Bhattacharjee 3:46 AM

-- August 30, 2025 --

?? ???, CDC ??? ?? ?? ??? ??? ?? RFK ??? ?? ?? Mohd Haider 10:55 PM

??????????CDC??????????????????????RFK Jr.?????? Mohd Haider 10:55 PM

Bernie Sanders exige la dmission du secrtaire la sant RFK Jr. alors que la crise du leadership au CDC s'aggrave Mohd Haider 10:55 PM

???? ?????? ????? ???????? ???? ????? RFK Jr. ?? ????? ???? ????? ???? ??????? ??? ??????? ???????? ???? Mohd Haider 10:55 PM

Bernie Sanders fordert den Rcktritt von Gesundheitsminister RFK Jr., da sich die Fhrungskrise der CDC vertieft Mohd Haider 10:55 PM

Bernie Sanders chiede le dimissioni del Segretario alla Salute RFK Jr. mentre si approfondisce la crisi di leadership dei CDC Mohd Haider 10:55 PM

????????????????,CDC?????? Mohd Haider 10:55 PM

Bernie Sanders exige la renuncia del Secretario de Salud RFK Jr. a medida que la crisis de liderazgo de los CDC se profundiza Mohd Haider 10:55 PM

Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens Mohd Haider 10:55 PM

-- August 28, 2025 --

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies PRNewswire 8:00 AM

-- August 27, 2025 --

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2 ACCESS Newswire 2:01 PM

-- August 22, 2025 --

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 ACCESS Newswire 9:25 AM

-- August 21, 2025 --

Biotechs Big Bang: IPOs, Uplists and the Short Squeeze Effect Yolowire 7:41 AM

Moderna to Present at Upcoming Conferences in September 2025 ACCESS Newswire 7:11 AM

-- August 11, 2025 --

Ajit Singh Appointed CEO of Harbinger Health and CEO-Partner of Flagship Pioneering PRNewswire 12:00 PM

-- August 1, 2025 --

Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates ACCESS Newswire 7:11 AM

UK Court of Appeal Confirms Moderna's EP'949 Patent is Valid and Infringed by Pfizer/BioNTech ACCESS Newswire 6:11 AM

-- July 30, 2025 --

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1 ACCESS Newswire 4:11 PM

-- July 28, 2025 --

Moderna Announces Data to be Presented at ESMO Congress 2025 ACCESS Newswire 7:11 AM

-- July 25, 2025 --

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1 ACCESS Newswire 8:51 AM